LOS ANGELES & BOSTON--(BUSINESS WIRE)--Vida Ventures (“Vida”), a next-generation life sciences venture firm, today congratulates Aktis Oncology (Nasdaq: AKTS), a clinical-stage biotechnology company ...
UAE-based CE‑Ventures, the VC arm of Crescent Enterprises, has participated in a $55 million Series A funding round for ...
, one of the MEA's leading seed and early stage venture capital firms that also runs startup programs, has announced a new corporate structure for itself. Under the new setup, F6 Ventures, a newly ...
Earnings Call Insights: Harmony Biosciences Holdings, Inc. (HRMY) Q2 2025 Management reiterated full year revenue guidance of $820 million to $860 million and maintained their projection that WAKIX is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results